⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2016Cancer Biology and MedicineOpen Access

Ki-67 as a prognostic marker according to breast cancer molecular subtype

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Ki-67 may be considered as a valuable biomarker in breast cancer patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Soliman et al. (2016) studied this question.

synapsesocial.com/papers/69d70c1fe328128020aa8b5c https://doi.org/10.20892/j.issn.2095-3941.2016.0066

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upOriginal Research · 1991 · 6,209 citations
2Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyOriginal Research · 2006 · 3,871 citations
3Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) PatientsPrognostic Study · 2015 · 72 citations
4Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the LiverPrognostic Study · 2011 · 332 citations
5Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Decision Analysis · 2009 · 1,380 citations